Smith & Howard Wealth Management, LLC Bristol Myers Squibb CO Transaction History

Smith & Howard Wealth Management, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 05, 2022	BUY	$72.62 - $79.98 $195,928 - $215,786	2,698 New	2,698 $208,000
Q4 2020 Feb 04, 2021	SELL	$57.74 - $65.43 $812,863 - $921,123	-14,078 Closed	0 $0
Q2 2020 Aug 04, 2020	SELL	$54.82 - $64.09 $15,294 - $17,881	-279 Reduced 1.94%	14,078 $828,000
Q1 2020 Apr 22, 2020	SELL	$46.4 - $67.43 $8,120 - $11,800	-175 Reduced 1.2%	14,357 $800,000
Q4 2019 Jan 13, 2020	BUY	$49.21 - $64.19 $715,119 - $932,809	14,532 New	14,532 $933,000

2,428

1.5B

29.7M

32.2M

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $113B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

Get notified when there are updates to the investment portfolio of Smith & Howard Wealth Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Smith & Howard Wealth Management, LLC with notifications on news.